Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathryn Tremolet de Villers"'
Autor:
Caroline Goldin, Stefan Sillau, Elisa Worledge, Jarrett Bremmer, Robbie Cummins, Kathryn Tremolet de Villers, Michelle E. Fullard
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
BackgroundThe administration of antidopaminergic medications to patients with Parkinson’s disease (PD) can exacerbate symptoms, and in the hospital setting, can lead to complications and increased length of stay. Despite efforts to improve medicati
Externí odkaz:
https://doaj.org/article/ddcdf3cefed7471ca708b46366b1be87
Autor:
Caroline Goldin, Elisa Worledge, Jarrett Bremmer, Kathryn Tremolet de Villers, Robbie Cummins, Michelle Fullard
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d029ce60d53c2e6502c3aefd00d37169
https://doi.org/10.1212/wnl.0000000000203208
https://doi.org/10.1212/wnl.0000000000203208
Autor:
Caitlin Rublee, Emilie Calvello Hynes, Nicole Paavola, Kathryn Tremolet de Villers, Julie McLaughlin
Publikováno v:
Journal of pharmacy practice.
Background: Levetiracetam is a readily available, safe anticonvulsive medication. It is frequently administered as IV piggyback with a pump, carrier fluid, and tubing. The Established Status Epilepticus Treatment Trial demonstrated levetiracetam bein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::155745708d43f452c6a47e0eb578fb3a
https://pubmed.ncbi.nlm.nih.gov/36189751
https://pubmed.ncbi.nlm.nih.gov/36189751
Publikováno v:
The Annals of pharmacotherapy. 55(3)
Background: Clinical practice guidelines recommend that cerebral venous thrombosis (CVT) be managed with long-term anticoagulant therapy using warfarin or low-molecular-weight heparin (LMWH) for 3 to 12 months. However, oral factor Xa inhibitors may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30709c402b2085bd804ad62fdaabce64
https://pubmed.ncbi.nlm.nih.gov/32844675
https://pubmed.ncbi.nlm.nih.gov/32844675